{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T03:00:04Z","timestamp":1794970804024,"version":"4.9.1"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T00:00:00Z","timestamp":1762128000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T00:00:00Z","timestamp":1762128000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81870056"],"award-info":[{"award-number":["81870056"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Key Technologies R & D Program Precision Medicine Research","award":["2021YFC2500700 and 2016YFC0901101"],"award-info":[{"award-number":["2021YFC2500700 and 2016YFC0901101"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pulm Med"],"DOI":"10.1186\/s12890-025-03962-w","type":"journal-article","created":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T10:46:34Z","timestamp":1762166794000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Longitudinal change of idiopathic inflammatory myopathy-associated interstitial lung disease on high-resolution computed tomography, a prospective cohort study"],"prefix":"10.1186","volume":"25","author":[{"given":"Yuhui","family":"Qiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongyi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yifei","family":"Ni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianping","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anqi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linfeng","family":"Xi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinan","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanhong","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bingbing","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiyao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Geng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huaping","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,3]]},"reference":[{"key":"3962_CR1","doi-asserted-by":"crossref","unstructured":"Douglas WW. Polymyositis-dermatomyositis-associated interstitial lung. Am J Respir Crit Care Med. 2001.","DOI":"10.1164\/ajrccm.164.7.2103110"},{"issue":"2","key":"3962_CR2","doi-asserted-by":"publisher","first-page":"109","DOI":"10.3233\/JND-180308","volume":"5","author":"J Schmidt","year":"2018","unstructured":"Schmidt J. Current classification and management of inflammatory myopathies. J Neuromuscul Dis. 2018;5(2):109\u201329.","journal-title":"J Neuromuscul Dis"},{"issue":"1","key":"3962_CR3","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1111\/joim.12451","volume":"280","author":"Z Betteridge","year":"2016","unstructured":"Betteridge Z, McHugh N. Myositis-specific autoantibodies: an important tool to support diagnosis of myositis. J Intern Med. 2016;280(1):8\u201323.","journal-title":"J Intern Med"},{"issue":"4","key":"3962_CR4","volume":"38","author":"Y Lia","year":"2022","unstructured":"Lia Y, Fana Y, Wanga Y, Yanga S, Dua X, Yea Q. Phenotypic clusters and survival analyses in interstitial pneumonia with myositis-specific autoantibodies. Sarcoidosis Vasc Diffuse Lung Dis. 2022;38(4):e2021047.","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"issue":"4","key":"3962_CR5","doi-asserted-by":"publisher","DOI":"10.1007\/s11926-018-0732-6","volume":"20","author":"I Pinal-Fernandez","year":"2018","unstructured":"Pinal-Fernandez I, Casal-Dominguez M, Mammen AL. Immune-mediated necrotizing myopathy. Curr Rheumatol Rep. 2018;20(4):21.","journal-title":"Curr Rheumatol Rep"},{"issue":"7","key":"3962_CR6","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.3899\/jrheum.161480","volume":"44","author":"J Shi","year":"2017","unstructured":"Shi J, Li S, Yang H, Zhang Y, Peng Q, Lu X, et al. Clinical profiles and prognosis of patients with distinct antisynthetase autoantibodies. J Rheumatol. 2017;44(7):1051\u20137.","journal-title":"J Rheumatol"},{"issue":"4","key":"3962_CR7","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0060442","volume":"8","author":"Y Hamaguchi","year":"2013","unstructured":"Hamaguchi Y, Fujimoto M, Matsushita T, Kaji K, Komura K, Hasegawa M, et al. Common and distinct clinical features in adult patients with anti-aminoacyl-tRNA synthetase antibodies: heterogeneity within the syndrome. PLoS ONE. 2013;8(4):e60442.","journal-title":"PLoS ONE"},{"key":"3962_CR8","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.845988","volume":"13","author":"Y Zuo","year":"2022","unstructured":"Zuo Y, Ye L, Chen F, Shen Y, Lu X, Wang G, et al. Different multivariable risk factors for rapid progressive interstitial lung disease in Anti-MDA5 positive dermatomyositis and Anti-Synthetase syndrome. Front Immunol. 2022;13:845988.","journal-title":"Front Immunol"},{"issue":"9","key":"3962_CR9","doi-asserted-by":"publisher","first-page":"e18","DOI":"10.1164\/rccm.202202-0399ST","volume":"205","author":"G Raghu","year":"2022","unstructured":"Raghu G, Remy-Jardin M, Richeldi L, Thomson CC, Inoue Y, Johkoh T, et al. Idiopathic pulmonary fibrosis (an Update) and progressive pulmonary fibrosis in adults: an official ATS\/ERS\/JRS\/ALAT clinical practice guideline. Am J Respir Crit Care Med. 2022;205(9):e18\u201347.","journal-title":"Am J Respir Crit Care Med"},{"issue":"8","key":"3962_CR10","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.1016\/j.rmed.2007.02.017","volume":"101","author":"J Won Huh","year":"2007","unstructured":"Won Huh J, Soon Kim D, Keun Lee C, Yoo B, Bum Seo J, Kitaichi M, et al. Two distinct clinical types of interstitial lung disease associated with polymyositis-dermatomyositis. Respir Med. 2007;101(8):1761\u20139.","journal-title":"Respir Med"},{"issue":"1","key":"3962_CR11","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01011-2016","volume":"49","author":"J Jacob","year":"2017","unstructured":"Jacob J, Bartholmai BJ, Rajagopalan S, Kokosi M, Nair A, Karwoski R, et al. Mortality prediction in idiopathic pulmonary fibrosis: evaluation of computer-based CT analysis with conventional severity measures. Eur Respir J. 2017. https:\/\/doi.org\/10.1183\/13993003.01011-2016","journal-title":"Eur Respir J"},{"issue":"1","key":"3962_CR12","doi-asserted-by":"publisher","DOI":"10.1186\/s12931-018-0918-5","volume":"19","author":"J Clukers","year":"2018","unstructured":"Clukers J, Lanclus M, Mignot B, Van Holsbeke C, Roseman J, Porter S, et al. Quantitative CT analysis using functional imaging is superior in describing disease progression in idiopathic pulmonary fibrosis compared to forced vital capacity. Respir Res. 2018;19(1):213.","journal-title":"Respir Res"},{"key":"3962_CR13","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kead122","author":"J Yeo","year":"2023","unstructured":"Yeo J, Yoon SH, Kim JY, Lee JS, Lee EY, Goo JM, et al. Quantitative interstitial lung disease scores in idiopathic inflammatory myopathies: longitudinal changes and clinical implications. Rheumatology (Oxford). 2023. https:\/\/doi.org\/10.1093\/rheumatology\/kead122.","journal-title":"Rheumatology (Oxford)"},{"issue":"3","key":"3962_CR14","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1513\/AnnalsATS.202101-044OC","volume":"19","author":"T Handa","year":"2022","unstructured":"Handa T, Tanizawa K, Oguma T, Uozumi R, Watanabe K, Tanabe N, et al. Novel artificial Intelligence-based technology for chest computed tomography analysis of idiopathic pulmonary fibrosis. Ann Am Thorac Soc. 2022;19(3):399\u2013406.","journal-title":"Ann Am Thorac Soc"},{"issue":"11","key":"3962_CR15","doi-asserted-by":"publisher","first-page":"3690","DOI":"10.1093\/rheumatology\/kead122","volume":"62","author":"J Yeo","year":"2023","unstructured":"Yeo J, Yoon SH, Kim JY, Lee JS, Lee EY, Goo JM, et al. Quantitative interstitial lung disease scores in idiopathic inflammatory myopathies: longitudinal changes and clinical implications. Rheumatology (Oxford). 2023;62(11):3690\u20139.","journal-title":"Rheumatology (Oxford)"},{"issue":"5","key":"3962_CR16","doi-asserted-by":"publisher","first-page":"3480","DOI":"10.1007\/s00330-021-08411-w","volume":"32","author":"A Laporte","year":"2022","unstructured":"Laporte A, Mariampillai K, Allenbach Y, Pasi N, Donciu V, Toledano D, et al. Idiopathic inflammatory myopathies: CT characteristics of interstitial lung disease and their association(s) with myositis-specific autoantibodies. Eur Radiol. 2022;32(5):3480\u20139.","journal-title":"Eur Radiol"},{"key":"3962_CR17","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.768052","volume":"8","author":"W Xu","year":"2021","unstructured":"Xu W, Wu W, Zheng Y, Chen Z, Tao X, Zhang D, et al. A computed tomography Radiomics-based prediction model on interstitial lung disease in Anti-MDA5-Positive dermatomyositis. Front Med. 2021;8:768052.","journal-title":"Front Med"},{"issue":"1","key":"3962_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-96292-w","volume":"11","author":"W Xu","year":"2021","unstructured":"Xu W, Wu W, Zhang D, Chen Z, Tao X, Zhao J, et al. A novel CT scoring method predicts the prognosis of interstitial lung disease associated with anti-MDA5 positive dermatomyositis. Sci Rep. 2021;11(1):17070.","journal-title":"Sci Rep"},{"key":"3962_CR19","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.h6819","volume":"352","author":"SC Mathai","year":"2016","unstructured":"Mathai SC, Danoff SK. Management of interstitial lung disease associated with connective tissue disease. BMJ. 2016;352:h6819.","journal-title":"BMJ"},{"key":"3962_CR20","doi-asserted-by":"crossref","unstructured":"Travis WD, Costabel U, Hansell DM, King TE Jr., Lynch DA, Nicholson AG, et al. An official American Thoracic Society\/European Respiratory Society statement: update of the international multidisciplinary classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med. 2013;188(6):733\u201348.","DOI":"10.1164\/rccm.201308-1483ST"},{"issue":"1","key":"3962_CR21","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.nmd.2019.10.005","volume":"30","author":"AL Mammen","year":"2020","unstructured":"Mammen AL, Allenbach Y, Stenzel W, Benveniste O, Group EtWS. 239th ENMC international workshop: classification of dermatomyositis, Amsterdam, the Netherlands, 14\u201316 december 2018. Neuromuscul Disord. 2020;30(1):70\u201392.","journal-title":"Neuromuscul Disord"},{"key":"3962_CR22","doi-asserted-by":"crossref","unstructured":"Bohan A. JBP. Polymyositis and dermatomyositis(first of two parts). the new england journal of medicine 1975.","DOI":"10.1056\/NEJM197502132920706"},{"key":"3962_CR23","doi-asserted-by":"publisher","DOI":"10.3390\/jcm8112013","author":"L Cavagna","year":"2019","unstructured":"Cavagna L, Trallero-Aragu\u00e1s E, Meloni F, Cavazzana I, Rojas-Serrano J, Feist E, et al. Influence of antisynthetase antibodies specificities on antisynthetase syndrome clinical spectrum time course. J Clin Med. 2019. https:\/\/doi.org\/10.3390\/jcm8112013","journal-title":"J Clin Med"},{"issue":"6","key":"3962_CR24","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1164\/rccm.2009-040GL","volume":"183","author":"G Raghu","year":"2011","unstructured":"Raghu G, Collard HR, Egan JJ, Martinez FJ, Behr J, Brown KK, et al. An official ATS\/ERS\/JRS\/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med. 2011;183(6):788\u2013824.","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"3962_CR25","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01499-2021","volume":"60","author":"S Stanojevic","year":"2022","unstructured":"Stanojevic S, Kaminsky DA, Miller MR, Thompson B, Aliverti A, Barjaktarevic I, et al. ERS\/ATS technical standard on interpretive strategies for routine lung function tests. Eur Respir J. 2022. https:\/\/doi.org\/10.1183\/13993003.01499-2021","journal-title":"Eur Respir J"},{"issue":"2","key":"3962_CR26","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1183\/09031936.05.00034805","volume":"26","author":"MR Miller","year":"2005","unstructured":"Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, et al. Standardisation of spirometry. Eur Respir J. 2005;26(2):319\u201338.","journal-title":"Eur Respir J"},{"issue":"7","key":"3962_CR27","doi-asserted-by":"publisher","first-page":"1779","DOI":"10.5664\/jcsm.9976","volume":"18","author":"XL Zhang","year":"2022","unstructured":"Zhang XL, Zhang L, Li YM, Xiang BY, Han T, Wang Y, et al. Multidimensional assessment and cluster analysis for OSA phenotyping. J Clin Sleep Med. 2022;18(7):1779\u201388.","journal-title":"J Clin Sleep Med"},{"key":"3962_CR28","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.b2393","volume":"338","author":"JA Sterne","year":"2009","unstructured":"Sterne JA, White IR, Carlin JB, Spratt M, Royston P, Kenward MG, et al. Multiple imputation for missing data in epidemiological and clinical research: potential and pitfalls. BMJ. 2009;338:b2393.","journal-title":"BMJ"},{"issue":"5","key":"3962_CR29","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1002\/art.23571","volume":"59","author":"M Fathi","year":"2008","unstructured":"Fathi M, Vikgren J, Boijsen M, Tylen U, Jorfeldt L, Tornling G, et al. Interstitial lung disease in polymyositis and dermatomyositis: longitudinal evaluation by pulmonary function and radiology. Arthritis Rheum. 2008;59(5):677\u201385.","journal-title":"Arthritis Rheum"},{"issue":"3","key":"3962_CR30","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1093\/rheumatology\/keaa372","volume":"60","author":"S Li","year":"2021","unstructured":"Li S, Sun Y, Shao C, Huang H, Wang Q, Xu K, et al. Prognosis of adult idiopathic inflammatory myopathy-associated interstitial lung disease: a retrospective study of 679 adult cases. Rheumatology (Oxford). 2021;60(3):1195\u2013204.","journal-title":"Rheumatology (Oxford)"},{"issue":"3","key":"3962_CR31","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1093\/rheumatology\/kep375","volume":"49","author":"R Nakashima","year":"2010","unstructured":"Nakashima R, Imura Y, Kobayashi S, Yukawa N, Yoshifuji H, Nojima T, et al. The RIG-I-like receptor IFIH1\/MDA5 is a dermatomyositis-specific autoantigen identified by the anti-CADM-140 antibody. Rheumatology (Oxford). 2010;49(3):433\u201340.","journal-title":"Rheumatology (Oxford)"},{"issue":"8","key":"3962_CR32","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1002\/acr.21985","volume":"65","author":"Z Chen","year":"2013","unstructured":"Chen Z, Cao M, Plana MN, Liang J, Cai H, Kuwana M, et al. Utility of anti-melanoma differentiation-associated gene 5 antibody measurement in identifying patients with dermatomyositis and a high risk for developing rapidly progressive interstitial lung disease: a review of the literature and a meta-analysis. Arthritis Care Res (Hoboken). 2013;65(8):1316\u201324.","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"1","key":"3962_CR33","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1186\/s13613-018-0433-3","volume":"8","author":"C Vuillard","year":"2018","unstructured":"Vuillard C, Pineton de Chambrun M, de Prost N, Guerin C, Schmidt M, Dargent A, et al. Clinical features and outcome of patients with acute respiratory failure revealing anti-synthetase or anti-MDA-5 dermato-pulmonary syndrome: a French multicenter retrospective study. Ann Intensive Care. 2018;8(1):87.","journal-title":"Ann Intensive Care"},{"key":"3962_CR34","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2023-003150","volume":"9","author":"X Chen","year":"2023","unstructured":"Chen X, Jiang W, Jin Q, Peng Q, Zhang L, Lin S, et al. Clinical, radiological and pathological features of anti-MDA5 antibody-associated interstitial lung disease. RMD Open. 2023. https:\/\/doi.org\/10.1136\/rmdopen-2023-003150","journal-title":"RMD Open"},{"issue":"5","key":"3962_CR35","doi-asserted-by":"publisher","first-page":"361","DOI":"10.2169\/internalmedicine.49.2889","volume":"49","author":"Y Koreeda","year":"2010","unstructured":"Koreeda Y, Higashimoto I, Yamamoto M, Takahashi M, Kaji K, Fujimoto M, et al. Clinical and pathological findings of interstitial lung disease patients with anti-aminoacyl-tRNA synthetase autoantibodies. Intern Med. 2010;49(5):361\u20139.","journal-title":"Intern Med"},{"key":"3962_CR36","unstructured":"Hayashi S. High resolution computed tomography characterization of interstitial lung diseases in polymyositis\/dermatomyositis. J Rheumatol. 2008."},{"issue":"5","key":"3962_CR37","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1016\/j.rmed.2013.01.014","volume":"107","author":"K Tanizawa","year":"2013","unstructured":"Tanizawa K, Handa T, Nakashima R, Kubo T, Hosono Y, Aihara K, et al. The prognostic value of HRCT in myositis-associated interstitial lung disease. Respir Med. 2013;107(5):745\u201352.","journal-title":"Respir Med"},{"issue":"10","key":"3962_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2023.103416","volume":"22","author":"S Abu-Rumeileh","year":"2023","unstructured":"Abu-Rumeileh S, Marrani E, Maniscalco V, Maccora I, Pagnini I, Mastrolia MV, et al. Lung involvement in juvenile idiopathic inflammatory myopathy: a systematic review. Autoimmun Rev. 2023;22(10):103416.","journal-title":"Autoimmun Rev"},{"issue":"1","key":"3962_CR39","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1097\/RLU.0000000000005429","volume":"50","author":"J Zhang","year":"2025","unstructured":"Zhang J, Dong A. FDG PET\/CT findings of rapidly progressive interstitial lung disease in a patient with anti-MDA5 dermatomyositis. Clin Nucl Med. 2025;50(1):80\u20132.","journal-title":"Clin Nucl Med"},{"issue":"16","key":"3962_CR40","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2313070121","volume":"121","author":"Y Ichimura","year":"2024","unstructured":"Ichimura Y, Konishi R, Shobo M, Tanaka R, Kubota N, Kayama H, et al. Autoimmunity against melanoma differentiation-associated gene 5 induces interstitial lung disease mimicking dermatomyositis in mice. Proc Natl Acad Sci U S A. 2024;121(16):e2313070121.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"3962_CR41","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1002\/acr.21895","volume":"65","author":"I Marie","year":"2013","unstructured":"Marie I, Josse S, Hatron PY, Dominique S, Hachulla E, Janvresse A, et al. Interstitial lung disease in anti-Jo-1 patients with antisynthetase syndrome. Arthritis Care Res (Hoboken). 2013;65(5):800\u20138.","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"1","key":"3962_CR42","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1136\/thx.2006.069237","volume":"63","author":"I Tillie-Leblond","year":"2008","unstructured":"Tillie-Leblond I, Wislez M, Valeyre D, Crestani B, Rabbat A, Israel-Biet D, et al. Interstitial lung disease and anti-Jo-1 antibodies: difference between acute and gradual onset. Thorax. 2008;63(1):53\u20139.","journal-title":"Thorax"},{"issue":"1","key":"3962_CR43","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1159\/000543083","volume":"17","author":"L Forde","year":"2025","unstructured":"Forde L, Gogoi D, Baird R, McCarthy C, Keane MP, Reeves EP, et al. Does adenosine triphosphate via purinergic receptor signalling fuel pulmonary fibrosis? J Innate Immun. 2025;17(1):44\u201355.","journal-title":"J Innate Immun"},{"key":"3962_CR44","doi-asserted-by":"publisher","first-page":"1479801","DOI":"10.3389\/fcimb.2024.1479801","volume":"14","author":"A Shadid","year":"2024","unstructured":"Shadid A, Rich HE, DeVaughn H, Domozhirov A, Doursout MF, Weng-Mills T, et al. Persistent microbial infections and idiopathic pulmonary fibrosis - an insight into non-typeable haemophilus influenza pathogenesis. Front Cell Infect Microbiol. 2024;14:1479801.","journal-title":"Front Cell Infect Microbiol"},{"key":"3962_CR45","doi-asserted-by":"publisher","DOI":"10.1183\/16000617.0139-2024","volume":"33","author":"LE Crowley","year":"2024","unstructured":"Crowley LE, Stockley RA, Thickett DR, Dosanjh D, Scott A, Parekh D. Neutrophil dynamics in pulmonary fibrosis: pathophysiological and therapeutic perspectives. Eur Respir Rev. 2024;33:174.","journal-title":"Eur Respir Rev"},{"issue":"50","key":"3962_CR46","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2401899121","volume":"121","author":"HN Nguyen","year":"2024","unstructured":"Nguyen HN, Jeong Y, Kim Y, Kamiya M, Kim Y, Athar H, et al. Leukemia inhibitory factor (LIF) receptor amplifies pathogenic activation of fibroblasts in lung fibrosis. Proc Natl Acad Sci U S A. 2024;121(50):e2401899121.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3962_CR47","doi-asserted-by":"crossref","unstructured":"Moussa N, Gargouri R, Snoussi M, Khemakhem R, Bahloul Z, Kammoun S. Nonspecific interstitial pneumonia revealing an antisynthetase syndrome. Monaldi Arch Chest Dis. 2022;93(3).","DOI":"10.4081\/monaldi.2022.2045"},{"key":"3962_CR48","doi-asserted-by":"publisher","DOI":"10.1016\/j.nmd.2024.104453","volume":"45","author":"W Stenzel","year":"2024","unstructured":"Stenzel W, Mammen AL, Gallay L, Holzer MT, Kleefeld F, Benveniste O, et al. 273rd ENMC international workshop: clinico-sero-morphological classification of the Antisynthetase syndrome. Amsterdam, The Netherlands, 27\u201329 October 2023. Neuromuscul Disord. 2024;45:104453.","journal-title":"Neuromuscul Disord"},{"issue":"7","key":"3962_CR49","doi-asserted-by":"publisher","first-page":"4746","DOI":"10.1007\/s00330-023-09439-w","volume":"33","author":"W Wu","year":"2023","unstructured":"Wu W, Collins BF, Gardner GC, Hippe DS, Ho LA, Raghu G, et al. Antisynthetase syndrome-related interstitial lung disease (ASyS-ILD): longitudinal imaging findings. Eur Radiol. 2023;33(7):4746\u201357.","journal-title":"Eur Radiol"},{"key":"3962_CR50","doi-asserted-by":"crossref","unstructured":"Sehgal S, Patel A, Chatterjee S, Fernandez AP, Farver C, Yadav R et al. Idiopathic inflammatory myopathies related lung disease in adults. Lancet Respir Med. 2024.","DOI":"10.1016\/S2213-2600(24)00267-4"},{"key":"3962_CR51","doi-asserted-by":"publisher","DOI":"10.1016\/j.tips.2025.01.005","author":"S Wischnewski","year":"2025","unstructured":"Wischnewski S, Rausch HW, Ikenaga C, Leipe J, Lloyd TE, Schirmer L. Emerging mechanisms and therapeutics in inflammatory muscle diseases. Trends Pharmacol Sci. 2025. https:\/\/doi.org\/10.1016\/j.tips.2025.01.005.","journal-title":"Trends Pharmacol Sci"},{"issue":"11","key":"3962_CR52","doi-asserted-by":"publisher","first-page":"3724","DOI":"10.1093\/rheumatology\/kead117","volume":"62","author":"Y Liu","year":"2023","unstructured":"Liu Y, Feng S, Liu X, Tang Y, Li X, Luo C, et al. IFN-beta and EIF2AK2 are potential biomarkers for interstitial lung disease in anti-MDA5 positive dermatomyositis. Rheumatology (Oxford). 2023;62(11):3724\u201331.","journal-title":"Rheumatology (Oxford)"},{"issue":"8","key":"3962_CR53","doi-asserted-by":"publisher","first-page":"2284","DOI":"10.1093\/rheumatology\/kead597","volume":"63","author":"J He","year":"2024","unstructured":"He J, Liu Z, Cao Y, Zhang X, Yi C, Zhou Y, et al. Single-cell landscape of peripheral immune response in patients with anti-melanoma differentiation-associated gene 5 dermatomyositis. Rheumatology (Oxford). 2024;63(8):2284\u201394.","journal-title":"Rheumatology (Oxford)"},{"issue":"5","key":"3962_CR54","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1097\/RTI.0000000000000659","volume":"37","author":"C Roncella","year":"2022","unstructured":"Roncella C, Barsotti S, Valentini A, Cavagna L, Castellana R, Cioffi E, et al. Evaluation of interstitial lung disease in idiopathic inflammatory myopathies through semiquantitative and quantitative analysis of lung computed tomography. J Thorac Imaging. 2022;37(5):344\u201351.","journal-title":"J Thorac Imaging"},{"issue":"5","key":"3962_CR55","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1007\/s00408-017-0035-0","volume":"195","author":"P Ungprasert","year":"2017","unstructured":"Ungprasert P, Wilton KM, Ernste FC, Kalra S, Crowson CS, Rajagopalan S, et al. Novel assessment of interstitial lung disease using the Computer-Aided lung informatics for pathology evaluation and rating (CALIPER) software system in idiopathic inflammatory myopathies. Lung. 2017;195(5):545\u201352.","journal-title":"Lung"},{"key":"3962_CR56","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2024-004592","volume":"10","author":"SS Bae","year":"2024","unstructured":"Bae SS, Abtin F, Kim G, Markovic D, Chan C, Moghadam-Kia S, et al. Relationship between high-resolution computed tomography quantitative imaging analysis and physiological and clinical features in antisynthetase syndrome-related interstitial lung disease. RMD Open. 2024. https:\/\/doi.org\/10.1136\/rmdopen-2024-004592","journal-title":"RMD Open"},{"issue":"6","key":"3962_CR57","doi-asserted-by":"publisher","first-page":"omae061","DOI":"10.1093\/omcr\/omae061","volume":"2024","author":"K Biddle","year":"2024","unstructured":"Biddle K, Agaoglu E, Brent G, Adam J, Nockels R, Loveridge A, et al. Two challenging cases of anti-MDA-5 dermatomyositis with rapidly progressive interstitial lung disease. Oxf Med Case Rep. 2024;2024(6):omae061.","journal-title":"Oxf Med Case Rep"},{"issue":"1","key":"3962_CR58","doi-asserted-by":"publisher","DOI":"10.1080\/07853890.2024.2440621","volume":"57","author":"F Xiao","year":"2025","unstructured":"Xiao F, Chen F, Li D, Zheng S, Liang X, Wu J, et al. Severe interstitial lung disease risk prediction in anti-melanoma differentiation-associated protein 5 positive dermatomyositis: the STRAD-Ro52 model. Ann Med. 2025;57(1):2440621.","journal-title":"Ann Med"}],"container-title":["BMC Pulmonary Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-025-03962-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12890-025-03962-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-025-03962-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T12:04:07Z","timestamp":1762171447000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpulmmed.biomedcentral.com\/articles\/10.1186\/s12890-025-03962-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,3]]},"references-count":58,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3962"],"URL":"https:\/\/doi.org\/10.1186\/s12890-025-03962-w","relation":{},"ISSN":["1471-2466"],"issn-type":[{"value":"1471-2466","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,3]]},"assertion":[{"value":"16 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethics Committee of China-Japan Friendship Hospital, and all procedures were conducted in accordance with the Declaration of Helsinki. Written informed consent was obtained from all participants (Approval number: 2017-25).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent for publication of their clinical details and\/or images was obtained from the patient.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"503"}}